DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7jbfwc/the) has announced the addition of the "The Pharmaceutical Market: Greece" report to their offering.
The immediate threat of a Greek default and eurozone exit was reduced as the outcome of the legislative elections in June had a much more benign outcome than many feared. An exit would have - and could still be - disastrous for drugmakers operating in the market. But even Greece staying in the monetary union means the government must continue with its austerity programme. While Germany and the rest of the EU are expected to reduce the focus on austerity and introduce some pro-growth strategies, these are unlikely to generate any upside for the pharmaceutical industry and structural reforms within Greece will be maintained.
Key Topics Covered
- SWOT
- Political
- Economic
- Business Environment
- Industry Forecast
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Key Risks To The Forecast Scenario
- Macroeconomic Forecasts
- Economic Analysis
- Industry Risk Reward Ratings
- Central And Eastern Europe Risk/Reward Ratings
- Greece Risk/Reward Ratings
- Rewards
- Risks
- Market Overview
- Industry Trends And Developments
- Epidemiology
- Healthcare Sector
- Healthcare Sector Developments
- Healthcare Insurance
- Healthcare Infrastructure
- Research And Development
- Clinical Trials
- Regulatory Development
- Intellectual Property Regime
- Pricing Regime
- Reimbursement Regime
- Competitive Landscape
- Company Activity
- Government Activity
- Parallel Pharmaceutical Exports
- Pharmaceutical Retail Sector
- Demographic Forecast
Glossary and Methodology
Companies Mentioned
- Abbott Laboratories
- Alapis Pharma
- Elpen
- Genesis Pharma
- GlaxoSmithKline
- Kleva
- Lavipharm
- Merck Sharp & Dohme
- Novartis
- Pfizer
- Pharmathen
- Sanofi
- Vianex
For more information visit http://www.researchandmarkets.com/research/7jbfwc/the
